HCM
BIO icon

Hollencrest Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Hollencrest Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$27.9K – 1246
2026
Q1 		$27.9K Buy
+100
New +$28.8K ﹤0.01% 670

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Hollencrest Capital Management's BIO Position: Q2 2026 in Review

Hollencrest Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 100 shares — an estimated $27.9K sold.

Hollencrest Capital Management first reported a position in BIO in Q1 2026 and held it in 1 quarter. The position peaked at $27.9K in Q1 2026. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Hollencrest Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • Hollencrest Capital Management sold 100 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $27.9K.
  • Hollencrest Capital Management first reported a position in Bio-Rad Laboratories Class A in Q1 2026 and held it in 1 quarter.
  • Hollencrest Capital Management's Bio-Rad Laboratories Class A position peaked at $27.9K in Q1 2026.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.